Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 928562, 21 pages
http://dx.doi.org/10.1155/2013/928562
Review Article

A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer

Department of Medical Genetics, Tehran University of Medical Sciences, School of Medicine, Tehran, Iran

Received 17 April 2013; Revised 31 July 2013; Accepted 15 August 2013

Academic Editor: Ana Maria Tari

Copyright © 2013 Fatemeh Karami and Parvin Mehdipour. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [68 citations]

The following is the list of published articles that have cited the current article.

  • Yang Wang, Xiaomei Chen, Xiaojing Chen, Qilong Chen, and Keke Huo, “Transcriptional Profiling and Dynamical Regulation Analysis Identify Potential Kernel Target Genes of SCYL1-BP1 in HEK293T Cells,” Molecules and Cells, vol. 37, no. 9, pp. 691–698, 2014. View at Publisher · View at Google Scholar
  • Luigi Minafra, and Valentina Bravata, “Cell and molecular response to IORT treatment,” Translational Cancer Research, vol. 3, no. 1, pp. 32–47, 2014. View at Publisher · View at Google Scholar
  • G. Ponti, E. Castellsagué, C. Ruini, A. Percesepe, and A. Tomasi, “Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome,” Clinical Genetics, 2014. View at Publisher · View at Google Scholar
  • M. William Audeh, “Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition,” Pharmacogenomics and Personalized Medicine, vol. 7, pp. 307–316, 2014. View at Publisher · View at Google Scholar
  • G. Ponti, M. Manfredini, A. Tomasi, and G. Pellacani, “Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge,” Gene, 2015. View at Publisher · View at Google Scholar
  • Daniela Dacheva, Rumyana Dodova, Ivan Popov, Teodora Goranova, Atanaska Mitkova, Vanio Mitev, and Radka Kaneva, “Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing,” Molecular Diagnosis & Therapy, 2015. View at Publisher · View at Google Scholar
  • Nagi S. El Saghir, Nathalie K. Zgheib, Hussein A. Assi, Katia E. Khoury, Yannick Bidet, Sara M. Jaber, Raghid N. Charara, Rania A. Farhat, Firas Y. Kreidieh, Stephanie Decousus, Pierre Romero, Georges M. Nemer, Ziad Salem, Ali Shamseddine, Arafat Tfayli, Jaber Abbas, Faek Jamali, Muhieddine Seoud, Deborah K. Armstrong, Yves-Jean Bignon, and Nancy Uhrhammer, “BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer,” Oncologist, vol. 20, no. 4, pp. 357–364, 2015. View at Publisher · View at Google Scholar
  • Bradley M. Turner, and David G. Hicks, “Breast Cancer,” Family Medicine, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Adrien Saliou, François-Clément Bidard, Olivier Lantz, Marc-Henri Stern, Anne Vincent-Salomon, Charlotte Proudhon, and Jean-Yves Pierga, “Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions,” Expert Review of Molecular Diagnostics, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Edmund M. Der, Richard K. Gyasi, Yao Tettey, Lawrence Edusei, Marcel T. Bayor, Evelyn Jiagge, Mawuli Gyakobo, Sofia D. Merajver, and Lisa A. Newman, “Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience,” The Breast Journal, vol. 21, no. 6, pp. 627–633, 2015. View at Publisher · View at Google Scholar
  • Ielizaveta Gorodetska, Svitlana Serga, Natalia Levkovich, Tetiana Lahuta, Ludmila Ostapchenko, Serhyi Demydov, Nikolay Anikusko, Valeriy Cheshuk, Ivan Smolanka, Svitlana Sklyar, Serhyi Polenkov, Oleksander Boichenko, and Iryna Kozeretska, “The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine,” Hereditary Cancer in Clinical Practice, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Lisa A. Newman, “Disparities in Breast Cancer and African Ancestry: A Global Perspective,” The Breast Journal, 2015. View at Publisher · View at Google Scholar
  • Abdelilah Laraqui, Nancy Uhrhammer, Hicham EL Rhaffouli, Yassine Sekhsokh, Idriss Lahlou-Amine, Tahar Bajjou, Farida Hilali, Jamila El Baghdadi, Abderrahmane Al Bouzidi, Youssef Bakri, Said Amzazi, and Yves-Jean Bignon, “ BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African ,” Disease Markers, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Bradley M. Turner, and David G. Hicks, “Breast Cancer,” Family Medicine, pp. 1425–1434, 2016. View at Publisher · View at Google Scholar
  • Zdenek Kleibl, and Vessela N. Kristensen, “Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management,” Breast, vol. 28, pp. 136–144, 2016. View at Publisher · View at Google Scholar
  • F. Lhota, P. Zemankova, P. Kleiblova, J. Soukupova, M. Vocka, V. Stranecky, M. Janatova, H. Hartmannova, K. Hodanova, S. Kmoch, and Z. Kleibl, “ Hereditary truncating mutations of DNA repair and other genes in BRCA1 / BRCA2 / PALB2 -negatively tested breast cancer patients ,” Clinical Genetics, vol. 90, no. 4, pp. 324–333, 2016. View at Publisher · View at Google Scholar
  • Ashraf U Mannan, Jaya Singh, Ravikiran Lakshmikeshava, Nishita Thota, Suhasini Singh, T S Sowmya, Avshesh Mishra, Aditi Sinha, Shivani Deshwal, Megha R Soni, Anbukayalvizhi Chandrasekar, Bhargavi Ramesh, Bharat Ramamurthy, Shila Padhi, Payal Manek, Ravi Ramalingam, Suman Kapoor, Mithua Ghosh, Satish Sankaran, Arunabha Ghosh, Vamsi Veeramachaneni, Preveen Ramamoorthy, Ramesh Hariharan, and Kalyanasundaram Subramanian, “Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India,” Journal of Human Genetics, 2016. View at Publisher · View at Google Scholar
  • Hadis Daraee, Hammed T. Aiyelabegan, Babak Negahdari, Bahram Rajeian, Nosratollah Zarghami, and Ali Eatemadi, “Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line,” Biomedicine and Pharmacotherapy, vol. 84, pp. 1915–1922, 2016. View at Publisher · View at Google Scholar
  • Ivana Antonucci, Martina Provenzano, Luca Sorino, Michela Balsamo, Gitana Maria Aceto, Pasquale Battista, David Euhus, Ettore Cianchetti, Patrizia Ballerini, Clara Natoli, Giandomenico Palka, and Liborio Stuppia, “Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer,” Journal of Human Genetics, vol. 62, no. 3, pp. 379–387, 2016. View at Publisher · View at Google Scholar
  • Karolina N. Dziadkowiec, Emilia Gasiorowska, Ewa Nowak-Markwitz, and Anna Jankowska, “PARP inhibitors: Review of mechanisms of action and BRCA1/2 mutation targeting,” Przeglad Menopauzalny, vol. 15, no. 4, pp. 215–219, 2016. View at Publisher · View at Google Scholar
  • Sanjay Shahi, Dipendra Raj Pandeya, Bal Hari Poudel, Bibek Bhatta, Roshina Thapa, and Yogesh Bhatta, “A pilot study on screening of BRCA1 mutations (185delAG, 1294del40) in Nepalese breast cancer patients,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 4, pp. 1829–1832, 2016. View at Publisher · View at Google Scholar
  • Mohamed Elmogtba Mouaweia Mohamed Aabdein, Alsmawal Awad Mohammed Elimam, Hisham N. Altayb, Mohamed El-Fatih Mohy Eldeen, Mosab Mohamed Gasemelseed, Afra AbdElhamid FadlAlla, Marwa Mohamed Osman, Soada Ahmed Osman, Hajir Ali Saeed, Mona ShamsAldeen Ali, Tomador Siddig, Reem Abdelrahman Osman, Rehab Ahmed Elhadi, Muzamil Mahdi Abdel Hamid, and Mohamed Ahmed Salih, “BRCA1 novel mutation V1736D and in silico analysis of SNP Q356R in Sudanese patients with breast cancer,” F1000Research, vol. 6, pp. 1461, 2017. View at Publisher · View at Google Scholar
  • Asaad Azarnezhad, and Parvin Mehdipour, “Cancer Genetics at a Glance: The Comprehensive Insights,” Cancer Genetics and Psychotherapy, pp. 79–389, 2017. View at Publisher · View at Google Scholar
  • Kiven Erique Lukong, Yetunde Ogunbolude, and Jean Paul Kamdem, “Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • Lisa A. Newman, “Breast Cancer Disparities: Socioeconomic Factors versus Biology,” Annals of Surgical Oncology, 2017. View at Publisher · View at Google Scholar
  • Mohamed Elmogtba Mouaweia Mohamed Aabdein, Alsmawal Awad Mohammed Elimam, Hisham N. Altayb, Mohamed El-Fatih Mohy Eldeen, Mosab Mohamed Gasemelseed, Afra AbdElhamid FadlAlla, Marwa Mohamed Osman, Soada Ahmed Osman, Hajir Ali Saeed, Mona ShamsAldeen Ali, Tomador Siddig, Reem Abdelrahman Osman, Rehab Ahmed Elhadi, Muzamil Mahdi Abdel Hamid, and Mohamed Ahmed Salih, “BRCA1 novel mutation V1736D and in silico analysis of SNP Q356R in Sudanese patients with breast cancer,” F1000Research, vol. 6, pp. 1461, 2017. View at Publisher · View at Google Scholar
  • Eike Nohdurft, Elisa Long, and Stefan Spinler, “Was Angelina Jolie Right? Optimizing Cancer Prevention Strategies Among BRCA Mutation Carriers,” Decision Analysis, 2017. View at Publisher · View at Google Scholar
  • Helena Kääriäinen, Juha Muilu, Markus Perola, and Kati Kristiansson, “Genetics in an isolated population like Finland: a different basis for genomic medicine?,” Journal of Community Genetics, 2017. View at Publisher · View at Google Scholar
  • Jose Buleje, Maria Guevara-Fujita, Oscar Acosta, Francia D. P. Huaman, Pierina Danos, Alexis Murillo, Joseph A. Pinto, Jhajaira M. Araujo, Alfredo Aguilar, Jaime Ponce, Carlos Vigil, Carlos Castaneda, Gabriela Calderon, Henry L. Gomez, and Ricardo Fujita, “ Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer ,” Molecular Genetics & Genomic Medicine, 2017. View at Publisher · View at Google Scholar
  • Lisa A. Newman, and Linda M. Kaljee, “Health disparities and triple-negative breast cancer in african American women a review,” JAMA Surgery, vol. 152, no. 5, pp. 485–493, 2017. View at Publisher · View at Google Scholar
  • Golnaz Khakpour, Mehrdad Noruzinia, Pantea Izadi, Fatemeh Karami, Mohammad Ahmadvand, Ramin Heshmat, Mahsa M Amoli, and Javad Tavakkoly-Bazzaz, “Methylomics of breast cancer: Seeking epimarkers in peripheral blood of young subjects,” Tumor Biology, vol. 39, no. 3, pp. 101042831769504, 2017. View at Publisher · View at Google Scholar
  • Luisel Ricks-Santi, Georgia Dunston, J. Tyson McDonald, Bert Gold, Michael Dean, Nicole Thompson, Muneer Abbas, Bradford Wilson, Yasmine Kanaan, and Tammey J. Naab, “Next generation sequencing reveals high prevalence of BRCA1 and BRCA2 variants of unknown significance in early-onset breast cancer in African American women,” Ethnicity and Disease, vol. 27, no. 2, pp. 169–178, 2017. View at Publisher · View at Google Scholar
  • Nadezda Cherdyntseva, Polina Gervas, Elena Voropaeva, Evgeny Denisov, Lubov Pisareva, Elena Malinovskaya, Vladimir Maksimov, Michail Voevoda, Dmitriy Perinov, Yelena Panferova, Evgeny Cherdyntsev, and Evgeny Choynzonov, “New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families,” Cancer Biomarkers, vol. 18, no. 3, pp. 291–296, 2017. View at Publisher · View at Google Scholar
  • Mina Darooei, Subhadra Poornima, Bibi Umae Salma, Gayatri R Iyer, Akhilesh N Pujar, Srirambhatla Annapurna, Ashwin Shah, Srinivas Maddali, and Qurratulain Hasan, “Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population,” Tumor Biology, vol. 39, no. 2, pp. 101042831769430, 2017. View at Publisher · View at Google Scholar
  • Yuya Kobayashi, Shan Yang, Keith Nykamp, John Garcia, Stephen E. Lincoln, and Scott E. Topper, “Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation,” Genome Medicine, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar
  • Somayeh Reisi, Maryam Peymani, and Moslem Nurozpour Mamasani, “Down-regulation of BACH2 in formalin-fixed paraffin-embedded breast cancer tissue as transcriptional regulation in cancer,” Iranian Journal of Obstetrics, Gynecology and Infertility, vol. 20, no. 10, pp. 105–113, 2017. View at Publisher · View at Google Scholar
  • Mohamed Elmogtba Mouaweia Mohamed Aabdein, Alsmawal Awad Mohammed Elimam, Hisham N. Altayb, Mohamed El-Fatih Mohy Eldeen, Mosab Mohamed Gasemelseed, Afra AbdElhamid FadlAlla, Marwa Mohamed Osman, Soada Ahmed Osman, Hajir Ali Saeed, Mona ShamsAldeen Ali, Tomador Siddig, Reem Abdelrahman Osman, Rehab Ahmed Elhadi, Muzamil Mahdi Abdel Hamid, and Mohamed Ahmed Salih, “BRCA1 novel mutation V1736D and in silico analysis of SNP Q356R in Sudanese patients with breast cancer,” F1000Research, vol. 6, pp. 1461, 2017. View at Publisher · View at Google Scholar
  • Rachel G. Grashow, Vanessa Y. De La Rosa, Sean M. Watford, Janet M. Ackerman, and Ruthann A. Rudel, “BCScreen: A gene panel to test for breast carcinogenesis in chemical safety screening,” Computational Toxicology, 2017. View at Publisher · View at Google Scholar
  • Tingting Sun, Ilary Ruscito, Desislava Dimitrova, Radoslav Chekerov, Hagen Kulbe, Udo Baron, Véronique Blanchard, Pierluigi Benedetti Panici, Silvia Darb-Esfahani, Jalid Sehouli, Sven Olek, and Elena Ioana Braicu, “Genetic Versus Epigenetic BRCA1 Silencing Pathways,” International Journal of Gynecological Cancer, vol. 27, no. 8, pp. 1658–1665, 2017. View at Publisher · View at Google Scholar
  • Danielius Serapinas, Marius Sukys, Agne Bartkeviciute, Diana Barkauskiene, and Daiva Bartkeviciene, “The spectrum of the most common BRCA1/BRCA2 mutations in Lithuanian high risk families,” Genetika, vol. 49, no. 1, pp. 43–50, 2017. View at Publisher · View at Google Scholar
  • Maren Schmiester, and Ilja Demuth, “SNM1B/Apollo in the DNA damage response and telomere maintenance,” Oncotarget, vol. 8, no. 29, pp. 48398–48409, 2017. View at Publisher · View at Google Scholar
  • Ayca Gucalp, Tiffany A. Traina, Joel R. Eisner, Joel S. Parker, Sara R. Selitsky, Ben H. Park, Anthony D. Elias, Edwina S. Baskin-Bey, and Fatima Cardoso, “Male breast cancer: a disease distinct from female breast cancer,” Breast Cancer Research and Treatment, 2018. View at Publisher · View at Google Scholar
  • Ana Rafaela de Souza Timoteo, Ana Élida Menezes Magalhães Gonçalves, Lucas Amadeus Porpino Sales, Betina Menezes Albuquerque, Jorge Estefano Santana de Souza, Patrícia Cristina Pascoto de Moura, Marcos Alberto Arruda de Aquino, Lucymara Fassarela Agnez-Lima, and Tirzah Braz Petta Lajus, “A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer,” Breast Cancer Research and Treatment, 2018. View at Publisher · View at Google Scholar
  • Abdou Azaque Zoure, Youssef Bakri, Jacques Simpore, Meriem Slaoui, Hierrhum Aboubacar Bambara, Alexis Yobi Sawadogo, Tegwendé Rebeca Compaoré, Nabonswindé Lamoussa Marie Ouédraogo, Mohammed El Mzibri, Mohammed Attaleb, and Si Simon Traoré, “BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso,” Journal of Public Health in Africa, vol. 9, no. 1, pp. 11–15, 2018. View at Publisher · View at Google Scholar
  • Gamze Guney Eskiler, Gulsah Cecener, Unal Egeli, and Berrin Tunca, “ Triple negative breast cancer: new therapeutic approaches and BRCA status ,” Apmis, vol. 126, no. 5, pp. 371–379, 2018. View at Publisher · View at Google Scholar
  • Laura-Ancuta Pop, Roxana-Maria Cojocneanu-Petric, Valentina Pileczki, Gabriela Morar-Bolba, Alexandru Irimie, Vladimir Lazar, Claudio Lombardo, Angelo Paradiso, and Ioana Berindan-Neagoe, “Genetic alterations in sporadic triple negative breast cancer,” The Breast, vol. 38, pp. 30–38, 2018. View at Publisher · View at Google Scholar
  • Asaad Azarnezhad, and Parvin Mehdipour, “Five- hit hypothesis in ATM gene: An individualized model in a breast cancer patient,” Frontiers in Bioscience - Elite, vol. 10, no. 2, pp. 375–383, 2018. View at Publisher · View at Google Scholar
  • Sanghamitra Mylavarapu, Asmita Das, and Monideepa Roy, “Role of BRCA Mutations in the Modulation of Response to Platinum Therapy,” Frontiers in Oncology, vol. 8, 2018. View at Publisher · View at Google Scholar
  • Hikmat Abdel-Razeq, Amal Al-Omari, Farah Zahran, and Banu Arun, “Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan,” BMC Cancer, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar
  • Jaya Singh, Nishita Thota, Suhasini Singh, Shila Padhi, Puja Mohan, Shivani Deshwal, Soumit Sur, Mithua Ghosh, Amit Agarwal, Ramesh Sarin, Rosina Ahmed, Sachin Almel, Basumita Chakraborti, Vinod Raina, Praveen K. DadiReddy, B. K. Smruti, Senthil Rajappa, Chandragouda Dodagoudar, Shyam Aggarwal, Manish Singhal, Ashish Joshi, Rajeev Kumar, Ajai Kumar, Deepak K. Mishra, Neeraj Arora, Aarati Karaba, Satish Sankaran, Shanmukh Katragadda, Arunabha Ghosh, Vamsi Veeramachaneni, Ramesh Hariharan, and Ashraf U. Mannan, “Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations,” Breast Cancer Research and Treatment, vol. 170, no. 1, pp. 189–196, 2018. View at Publisher · View at Google Scholar
  • Yasaman-Sadat Borghei, Morteza Hosseini, Mohammad Reza Ganjali, and Huangxian Ju, “A unique FRET approach toward detection of single-base mismatch DNA in BRCA1 gene,” Materials Science and Engineering: C, 2018. View at Publisher · View at Google Scholar
  • Isabella Faraoni, and Grazia Graziani, “Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors,” Cancers, vol. 10, no. 12, pp. 487, 2018. View at Publisher · View at Google Scholar
  • Nadin Younes, and Hatem Zayed, “Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review,” Gene, 2018. View at Publisher · View at Google Scholar
  • Eduardo López-Urrutia, Victor Salazar-Rojas, Luis Brito-Elías, Misael Coca-González, Jonathan Silva-García, David Sánchez-Marín, Alma D. Campos-Parra, and Carlos Pérez-Plasencia, “BRCA mutations: is everything said?,” Breast Cancer Research and Treatment, 2018. View at Publisher · View at Google Scholar
  • Anjali Shailani, Raman Preet Kaur, and Anjana Munshi, “A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors,” Medical Oncology, vol. 35, no. 3, 2018. View at Publisher · View at Google Scholar
  • Melissa B. Davis, and Lisa A. Newman, “Breast Cancer Disparities,” Surgical Oncology Clinics of North America, vol. 27, no. 1, pp. 217–234, 2018. View at Publisher · View at Google Scholar
  • Babita Sharma, Raman Preet Kaur, Sonali Raut, and Anjana Munshi, “BRCA1 mutation spectrum, functions and therapeutic strategies: The story so far,” Current Problems in Cancer, 2018. View at Publisher · View at Google Scholar
  • Mohamed Elmogtba Mouaweia Mohamed Aabdein, Alsmawal Awad Mohammed Elimam, Hisham N. Altayb, Mohamed El-Fatih Mohy Eldeen, Mosab Mohamed Gasemelseed, Afra AbdElhamid FadlAlla, Marwa Mohamed Osman, Soada Ahmed Osman, Hajir Ali Saeed, Mona ShamsAldeen Ali, Tomador Siddig, Reem Abdelrahman Osman, Rehab Ahmed Elhadi, Muzamil Mahdi Abdel Hamid, and Mohamed Ahmed Salih, “BRCA1 novel variation V1736D and in silico analysis of SNP Q356R in Sudanese patients with breast cancer,” F1000Research, vol. 6, pp. 1461, 2018. View at Publisher · View at Google Scholar
  • Nidhi D. Shah, Mandava V. Rao, Yash Y. Panchal, Kalpesh H. Katudia, Nikunj B. Khatri, Upti R. Bhatiya, Bhavini S. Shah, Parth S. Shah, Hari Shankar P. Ray, and Sandip C. Shah, “Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients,” Application of Clinical Genetics, vol. 11, pp. 59–67, 2018. View at Publisher · View at Google Scholar
  • Shiena Enerio, Martha R. Stampfer, Deepa M. Sridharan, Chris Wang, Mark A. LaBarge, and Janice M. Pluth, “Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure,” Life Sciences in Space Research, 2018. View at Publisher · View at Google Scholar
  • Patricia A. Thompson, Christina Preece, and Alison T. Stopeck, “Breast Cancer Prevention,” Fundamentals of Cancer Prevention, pp. 543–606, 2019. View at Publisher · View at Google Scholar
  • Rinat Bernstein-Molho, Inbal Barnes-Kedar, Mark D. Ludman, Gili Reznik, Hagit Baris Feldman, Nadra Nasser Samra, Avital Eilat, Tamar Peretz, Lilach Peled Peretz, Tamar Shapira, Nurit Magal, Marina Lifshitc Kalis, Rinat Yerushalmi, Chana Vinkler, Sari Liberman, Lina Basel-Salmon, Mordechai Shohat, Ephrat Levy-Lahad, Eitan Friedman, Lily Bazak, and Yael Goldberg, “The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients,” Breast Cancer Research and Treatment, 2019. View at Publisher · View at Google Scholar
  • Polina Gervas, Boris Klyuch, Evgeny Denisov, Artem Kiselev, Alexey Molokov, Lubov Pisareva, Elena Malinovskaya, Evgeny Choynzonov, and Nadezda Cherdyntseva, “New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients,” Molecular Biology Reports, 2019. View at Publisher · View at Google Scholar
  • P. A. Gervas, A. Yu. Molokov, E. V. Panpherova, L. Ph. Pisareva, and N. V. Cherdyntseva, “Ethnic aspects of hereditary breast cancer,” Siberian journal of oncology, vol. 18, no. 2, pp. 102–108, 2019. View at Publisher · View at Google Scholar
  • E. A. Shestakova, and T. A. Bogush, “BRCA1 participates in the expression of noncoding XIST RNA,” Russian Journal of Biotherapy, vol. 18, no. 1, pp. 67–74, 2019. View at Publisher · View at Google Scholar
  • Xingyi Ma, Sojin Song, Soohyun Kim, Mi-sun Kwon, Hyunsook Lee, Wounjhang Park, and Sang Jun Sim, “Single gold-bridged nanoprobes for identification of single point DNA mutations,” Nature Communications, vol. 10, no. 1, 2019. View at Publisher · View at Google Scholar
  • Micah G. Donovan, Ornella I. Selmin, and Donato F. Romagnolo, “Prevention of Breast Cancer by Food Bioactives in Relation to Cancer Subtypes,” Epigenetics of Cancer Prevention, pp. 309–332, 2019. View at Publisher · View at Google Scholar
  • Hee Nam Kim, Min-Ho Shin, Ran Lee, Min-Ho Park, and Sun-Seog Kweon, “ Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients ,” Chonnam Medical Journal, vol. 55, no. 2, pp. 99, 2019. View at Publisher · View at Google Scholar